Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.

× No keyword cloud information.

22 in total

1. The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus.

Authors: N F Rothfield; B D Stollar
Journal: J Clin Invest Date: 1967-11 Impact factor: 14.808

2. The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses.

Authors: T K Burnham; G Fine; T R Neblett
Journal: Ann Intern Med Date: 1966-07 Impact factor: 25.391

3. Immunoglobulin class and pattern of nuclear fluorescence in systemic lupus erythematosus.

Authors: E N Gonzalez; N F Rothfield
Journal: N Engl J Med Date: 1966-06-16 Impact factor: 91.245

4. A.N.A.

Authors: P H Schur
Journal: N Engl J Med Date: 1970-05-21 Impact factor: 91.245

5. The clinical significance of titered antinuclear antibodies.

Authors: R F Ritchie
Journal: Arthritis Rheum Date: 1967-12

6. Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus.

Authors: E M Tan
Journal: J Lab Clin Med Date: 1967-11

7. Significance of nuclear immunofluorescent patterns.

Authors: C A Dorsch; C B Gibbs; M B Stevens; L E Shulman
Journal: Ann Rheum Dis Date: 1969-05 Impact factor: 19.103

8. Clinical and serologic observations on 27 patients with Felty's syndrome.

Authors: M Ruderman; L M Miller; R S Pinals
Journal: Arthritis Rheum Date: 1968-06

9. Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors: T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal: N Engl J Med Date: 1969-09-25 Impact factor: 91.245

10. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

Authors: N F Rothfield; G P Rodnan
Journal: Arthritis Rheum Date: 1968-10

3 in total

1. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.

Authors: L T Costallat; R M de Oliveira; M B Santiago; W Cossermelli; A M Samara
Journal: Clin Rheumatol Date: 1990-12 Impact factor: 2.980

2. Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors: Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal: Proc Natl Acad Sci U S A Date: 1980-03 Impact factor: 11.205

3. Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titer.

Authors: Peter N Malleson; Murray J Mackinnon; Michaela Sailer-Hoeck; Charles H Spencer
Journal: Pediatr Rheumatol Online J Date: 2010-10-20 Impact factor: 3.054

3 in total